This week on MIP: DABUS endgame, litigation funder battle

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

This week on MIP: DABUS endgame, litigation funder battle

Generative AI.jpeg

We provide a rundown of Managing IP’s news and analysis coverage from the week, and review what’s been happening elsewhere in IP

AI can’t invent, UK Supreme Court rules

The UK Supreme Court ruled unanimously that only people, not artificial intelligence tools, can be named as inventors under UK patent law.

The keenly awaited decision, on Wednesday, December 20, was a final defeat for the legal team behind the so-called DABUS case that sought to establish an AI tool as the inventor of a food storage system.

Click here to read more

Lawyers battle over litigation funder’s role in Microsoft patent dispute

A lawyer has asked to withdraw from a patent dispute involving Microsoft, citing a conflict with a litigation funder and allegedly unpaid fees.

William Ramey, a lawyer at Ramey LLP, filed a motion at the Court of Appeals for the Federal Circuit in which he asked to withdraw himself from CTD Networks v Microsoft.

Click here to read more

Other articles published by Managing IP this week include:

UK govt: AI inventorship reform must be global

Weekly take: Why 2023 was a mixed bag for the IP legal market

The IP Lounge: The top 50 in IP 2023, year in review

Five minutes with … Hiroyuki Hagiwara, Paul Hastings

Sources: IP lawyers well-placed to handle China’s diminishing judicial transparency

Behind the case: How Hungry Jack’s overcame TM beef over burger names

Elsewhere in IP

Watch stopped

Apple paused sales of some smart watches on Monday, December 18, amid a high-profile patent infringement row with medical technology company Masimo.

The US International Trade Commission imposed an import ban on the watches earlier this year after Apple was found to have infringed Masimo’s patents.

But that decision is subject to a potential veto by President Joe Biden, who has until December 25 to decide whether the ban should stand.

Apple said it was pausing sales of the allegedly infringing Apple Watch models as a pre-emptive measure.

Fantasy lawsuit

Amazon and the estate of fantasy writer JRR Tolkien have won a US copyright suit brought by the author of a so-called “sequel” to ‘Lord of the Rings’.

Demetrious Polychron filed the suit at the District Court for the District of California, claiming that Amazon’s “The Rings of Power” series copied his book “The Fellowship of the King”.

But Polychron’s complaint backfired when the Tolkien estate filed a countersuit for copyright infringement.

Judge Steven Wilson awarded Amazon and the Tolkien family $134,637 in attorney’s fees after finding Polychron’s suit was “frivolous from the beginning”.

SPC refusal

Merck has missed out on a supplementary protection certificate for multiple sclerosis drug cladribine after a defeat at the England and Wales High Court on Tuesday, December 19.

The UKIPO refused to grant the SPC for the drug, for which the patent will expire in December 2025, after finding Merck didn’t qualify under the Court of Justice of the EU’s Santen decision, issued in 2020.

Merck argued that it developed its cladribine product with the “legitimate expectation” that it would be entitled to an SPC under Neurim, an earlier CJEU decision from 2012.

But King's counsel Michael Tappin, sitting as a deputy high court judge, criticised this argument.

Price tag

The Unified Patent Court’s Munich Local Division refused to grant a preliminary injunction in a lawsuit over patents covering electronic price tags on Wednesday, December 20.

Judge Matthias Zigann said the court wasn’t satisfied that electronics company SES-imagotag’s patent was infringed by competitor Hanshow Technology.

The written order has yet to be published.

That's it for 2023, see you again next year. We wish you all a happy festive period and new year.

more from across site and SHARED ros bottom lb

More from across our site

Lawyers at Lavoix provide an overview of the UPC’s approach to inventive step and whether the forum is promoting its own approach rather than following the EPO
Andrew Blattman, who helped IPH gain significant ground in Asia and Canada, will leave in the second half of 2026
The court ordering a complainant to rank its arguments in order of potential success and a win for Edwards Lifesciences were among the top developments in recent weeks
Frederick Lee has rejoined Boies Schiller Flexner, bolstering the firm’s capabilities across AI, media, and entertainment
Nirav Desai and Sasha S Rao at Sterne, Kessler, Goldstein & Fox explore how companies’ efforts to manage tariffs by altering corporate structures can undermine their ability to assert their patents and recover damages
Monika Żuraw, founder of Żuraw & Partners, discusses why IP should be part of the foundation of a business, and taking on projects that others walk away from
Lawyers say attention will turn to the UK government’s AI consultation after judgment fails to match pre-trial hype
Susan Keston and Rachel Fetches at HGF explain why the CoA’s decision to grant the UPC’s first permanent injunction demonstrates the court’s readiness to diverge from national court judgments
IP, M&A, life sciences and competition partners advised on deal that brings together brands such as ‘Huggies’ and ‘Kleenex’ with ‘Band-Aid’ and ‘Tylenol’
Stability AI, represented by Bird & Bird, is not liable for secondary copyright infringement, though Fieldfisher client Getty succeeds in some trademark claims
Gift this article